Melatonin for Sleep Disorders and Cognition in Dementia: A Meta-Analysis of Randomized Controlled Trials
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The current review aims to examine melatonin therapy for both sleep disturbances and cognitive function in dementia. We searched all randomized controlled trials published in Medline, Embase, the Cochrane Library, China National Knowledge Infrastructure, the Cochrane Dementia and Cognitive Improvement Group’s Specialized Register, and Clinical Trials.gov . The grading of recommendations assessment, development and evaluation framework was used to assess the quality of evidence. Seven studies were included (n = 520). Treated participants showed prolonged total sleep time (TST) by 24.36 minutes ( P = .02). Sleep efficacy (SE) was marginally improved ( P = .07). This effect was stronger under a longer intervention period lasting more than 4 weeks ( P = .02). Conversely, cognitive function did not change significantly. Additionally, there was no report of severe adverse events. Given the current studies, we conclude that melatonin therapy may be effective in improving SE and prolonging TST in patients with dementia; however, there is no evidence that this improvement impacts cognitive function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 1×
“7 million in 2030.(1) Meanwhile, sleep disturbances become more common in late life and afflict between 19% and 50% of community-dwelling elderly patients affected with dementia.”
BackgroundInterpretation of random effects meta-analyses
Riley, R. D., Higgins, J. P. T., & Deeks, J. J. (2011) · BMJ · doi:10.1136/bmj.d549 · Cited by 2,884
Imputing missing standard deviations in meta-analyses can provide accurate results
Furukawa, T. A., Barbui, C., Cipriani, A., Brambilla, P., & Watanabe, N. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.06.006 · Cited by 1,568 · cited 1×
“In some cases, when standard deviations of changes could not be obtained, standard deviations from baseline were used.(26) Measurements (SE, TST, MMSE, and ADAS-cog) were considered as continuous outcomes and mean changes were expressed as mean difference (MD) and 95% confidence interval (95% CI).”
MethodRiemersma-van der Lek, R. F. (2008) · JAMA · doi:10.1001/jama.299.22.2642 · Cited by 803 · cited 10×
“studies.(21,23) One study reported AEs as abnormal behavior, aches/pain, falls, gastrointestinal distress, infection, respiratory/pulmonary symptoms, skin/subcutaneous tissue, and urinary symptoms, but no differences existed in mean number, severity, seriousness, or relatedness ratings of spontaneously reported AEs be…”
BackgroundInfluentialEffects of exogenous melatonin on sleep: a meta-analysis
Brzezinski, A., Vangel, M. G., Wurtman, R. J., Norrie, G., Zhdanova, I., Ben-Shushan, A., & Ford, I. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.06.004 · Cited by 541 · cited 2×
“Melatonin, the hormone secreted by the pineal gland, is believed to be effective in the treatment of sleep disturbance in healthy persons.(12) Disturbance in the circadian system and reduction of endogenous melatonin suggest a potential benefit of melatonin replacement therapy for dementia.”
BackgroundA Multicenter, Placebo-controlled Trial of Melatonin for Sleep Disturbance in Alzheimer's Disease
Singer, C., Tractenberg, R. E., Kaye, J., Schafer, K., Gamst, A., Grundman, M., Thomas, R., & Thal, L. J. (2003) · Sleep · doi:10.1093/sleep/26.7.893 · Cited by 407
Possible therapeutic value of melatonin in mild cognitive impairment: A retrospective study
Furio, A. M., Brusco, L. I., & Cardinali, D. P. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00491.x · Cited by 167 · cited 1×
“Studies investigating patients with mild cognitive impairment (MCI) revealed significant improvements in both cognition and sleep following melatonin replacement.(31,32) Patients with MCI showed cognitive amelioration as measured by MMSE, ADAScog, Trail A and B tasks, and the Rey verbal test.”
Method
Cited by
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Raulin, A.-C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C.-C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00574-4 · Cited by 756
“Recently, a meta-analysis of randomized control trials concluded that while melatonin improves total sleep time and sleep efficacy, cognitive function is not significantly altered [283].”
BackgroundDominguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13114080 · Cited by 433
Sleep Disturbance, Cognitive Decline, and Dementia: A Review
Wu, M., Rosenberg, P., Spira, A., & Wennberg, A. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1604351 · Cited by 309
Is Melatonin the Cornucopia of the 21st Century?
Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M. G., Rizzo, V., Currò, M., Ientile, R., & Caccamo, D. (2020) · Antioxidants · doi:10.3390/antiox9111088 · Cited by 189
Pharmacotherapies for sleep disturbances in dementia
McCleery, J., & Sharpley, A. L. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009178.pub4 · Cited by 128
Metadata
- Authors
- Xu, J., Wang, L.-L., Dammer, E. B., Li, C.-B., Xu, G., Chen, S.-D., & Wang, G.
- Venue
- American Journal of Alzheimer's Disease & Other Dementias®
- Publisher
- SAGE Publications
- Published
- 2015-01-22
- Volume
- 30
- Issue
- 5
- Pages
- 439-447
- ISSN
- 0888-4897 (ISSN-L)
- 1533-3175
- 1938-2731
- OpenAlex
- W2108257991
- Cited by
- 114
- References
- 9
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.